Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company CoCrystal Pharma Inc.
DescriptionPan-genotypic nonstructural protein 5A (NS5A) HCV inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat hepatitis C virus (HCV)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today